Loading...
Serum Detection of Nonadherence to Adjuvant Tamoxifen and Breast Cancer Recurrence Risk
PURPOSE: Nonadherence to long-term treatments is often under-recognized by physicians and there is no gold standard for its assessment. In breast cancer, nonadherence to tamoxifen therapy after surgery constitutes a major obstacle to optimal outcomes. We sought to evaluate the rate of biochemical no...
Na minha lista:
| Udgivet i: | J Clin Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Clinical Oncology
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7430219/ https://ncbi.nlm.nih.gov/pubmed/32568632 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.01758 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|